These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 29186568)
1. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis. Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568 [TBL] [Abstract][Full Text] [Related]
2. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Waszak SM; Northcott PA; Buchhalter I; Robinson GW; Sutter C; Groebner S; Grund KB; Brugières L; Jones DTW; Pajtler KW; Morrissy AS; Kool M; Sturm D; Chavez L; Ernst A; Brabetz S; Hain M; Zichner T; Segura-Wang M; Weischenfeldt J; Rausch T; Mardin BR; Zhou X; Baciu C; Lawerenz C; Chan JA; Varlet P; Guerrini-Rousseau L; Fults DW; Grajkowska W; Hauser P; Jabado N; Ra YS; Zitterbart K; Shringarpure SS; De La Vega FM; Bustamante CD; Ng HK; Perry A; MacDonald TJ; Hernáiz Driever P; Bendel AE; Bowers DC; McCowage G; Chintagumpala MM; Cohn R; Hassall T; Fleischhack G; Eggen T; Wesenberg F; Feychting M; Lannering B; Schüz J; Johansen C; Andersen TV; Röösli M; Kuehni CE; Grotzer M; Kjaerheim K; Monoranu CM; Archer TC; Duke E; Pomeroy SL; Shelagh R; Frank S; Sumerauer D; Scheurlen W; Ryzhova MV; Milde T; Kratz CP; Samuel D; Zhang J; Solomon DA; Marra M; Eils R; Bartram CR; von Hoff K; Rutkowski S; Ramaswamy V; Gilbertson RJ; Korshunov A; Taylor MD; Lichter P; Malkin D; Gajjar A; Korbel JO; Pfister SM Lancet Oncol; 2018 Jun; 19(6):785-798. PubMed ID: 29753700 [TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review. Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294 [TBL] [Abstract][Full Text] [Related]
4. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma. Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086 [TBL] [Abstract][Full Text] [Related]
5. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant]. Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947 [TBL] [Abstract][Full Text] [Related]
6. Retrospective family study of childhood medulloblastoma. Ng D; Stavrou T; Liu L; Taylor MD; Gold B; Dean M; Kelley MJ; Dubovsky EC; Vezina G; Nicholson HS; Byrne J; Rutka JT; Hogg D; Reaman GH; Goldstein AM Am J Med Genet A; 2005 May; 134(4):399-403. PubMed ID: 15759260 [TBL] [Abstract][Full Text] [Related]
7. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540 [TBL] [Abstract][Full Text] [Related]
10. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation. Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011 [TBL] [Abstract][Full Text] [Related]
11. Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations. Brugières L; Pierron G; Chompret A; Paillerets BB; Di Rocco F; Varlet P; Pierre-Kahn A; Caron O; Grill J; Delattre O J Med Genet; 2010 Feb; 47(2):142-4. PubMed ID: 19833601 [TBL] [Abstract][Full Text] [Related]
12. First evidence of genotype-phenotype correlations in Gorlin syndrome. Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of medulloblastomas with extensive nodularity (MBEN). Korshunov A; Sahm F; Stichel D; Schrimpf D; Ryzhova M; Zheludkova O; Golanov A; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M Acta Neuropathol; 2018 Aug; 136(2):303-313. PubMed ID: 29569031 [TBL] [Abstract][Full Text] [Related]
14. High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. Brugières L; Remenieras A; Pierron G; Varlet P; Forget S; Byrde V; Bombled J; Puget S; Caron O; Dufour C; Delattre O; Bressac-de Paillerets B; Grill J J Clin Oncol; 2012 Jun; 30(17):2087-93. PubMed ID: 22508808 [TBL] [Abstract][Full Text] [Related]
15. Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature. Siegfried A; Bertozzi AI; Bourdeaut F; Sevely A; Loukh N; Grison C; Miquel C; Lafon D; Sevenet N; Pietsch T; Dufour C; Delisle MB Clin Neuropathol; 2016; 35(3):106-13. PubMed ID: 26857864 [TBL] [Abstract][Full Text] [Related]
16. Retrospective investigation of hereditary syndromes in patients with medulloblastoma in a single institution. Wang Y; Wu J; Li W; Li J; Liu R; Yang B; Li C; Jiang T Childs Nerv Syst; 2021 Feb; 37(2):411-417. PubMed ID: 32930885 [TBL] [Abstract][Full Text] [Related]
17. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations. Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061 [TBL] [Abstract][Full Text] [Related]
18. Rapid diagnosis of medulloblastoma molecular subgroups. Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292 [TBL] [Abstract][Full Text] [Related]
19. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). Gajjar A; Robinson GW; Smith KS; Lin T; Merchant TE; Chintagumpala M; Mahajan A; Su J; Bouffet E; Bartels U; Schechter T; Hassall T; Robertson T; Nicholls W; Gururangan S; Schroeder K; Sullivan M; Wheeler G; Hansford JR; Kellie SJ; McCowage G; Cohn R; Fisher MJ; Krasin MJ; Stewart CF; Broniscer A; Buchhalter I; Tatevossian RG; Orr BA; Neale G; Klimo P; Boop F; Srinivasan A; Pfister SM; Gilbertson RJ; Onar-Thomas A; Ellison DW; Northcott PA J Clin Oncol; 2021 Mar; 39(7):822-835. PubMed ID: 33405951 [TBL] [Abstract][Full Text] [Related]